Coherus Biosciences narrows losses By: MarketMinute.com Stock News March 09, 2018 at 17:02 PM EST Coherus Biosciences Inc. (Nasdaq: CHRS) narrowed losses for the fourth quarter sending the stock price soaring $2.75 to close at $11.85. Related Stocks: Coherus Bio